Anifat A. Elegbede

Calgary, AB, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Genome-wide Detection of Chimeric Transcripts in Early-stage Non-small Cell Lung Cancer.

Genome-wide Detection of Chimeric Transcripts in Early-stage Non-small Cell Lung Cancer.

Journal: Cancer genomics & proteomics

Published: January 04, 2023

Real-World Management and Outcomes of Crizotinib-Treated ROS1-Rearranged NSCLC: A Retrospective Canadian Cohort.

Real-World Management and Outcomes of Crizotinib-Treated ROS1-Rearranged NSCLC: A Retrospective Canadian Cohort.

Journal: Current oncology (Toronto, Ont.)

Published: January 31, 2022

A Real-World Evaluation of Atezolizumab Plus Platinum-Etoposide Chemotherapy in Patients With Extensive-Stage SCLC in Canada.

A Real-World Evaluation of Atezolizumab Plus Platinum-Etoposide Chemotherapy in Patients With Extensive-Stage SCLC in Canada.

Journal: JTO clinical and research reports

Published: August 06, 2021

Retrospective Real-World Outcomes for Patients With ALK-Rearranged Lung Cancer Receiving ALK Receptor Tyrosine Kinase Inhibitors.

Retrospective Real-World Outcomes for Patients With ALK-Rearranged Lung Cancer Receiving ALK Receptor Tyrosine Kinase Inhibitors.

Journal: JTO clinical and research reports

Published: October 29, 2020

Real-World Adherence to Guideline-Recommended Treatment for Small Cell Lung Cancer.

Real-World Adherence to Guideline-Recommended Treatment for Small Cell Lung Cancer.

Journal: American journal of clinical oncology

Published: December 17, 2019

Impact of Asian ethnicity on outcome in metastatic EGFR-mutant non-small cell lung cancer.

Impact of Asian ethnicity on outcome in metastatic EGFR-mutant non-small cell lung cancer.

Journal: Asia-Pacific journal of clinical oncology

Published: June 13, 2019

Factors associated with early mortality in non-small cell lung cancer patients following systemic anti-cancer therapy: A 10 year population-based study.

Factors associated with early mortality in non-small cell lung cancer patients following systemic anti-cancer therapy: A 10 year population-based study.

Journal: Lung cancer (Amsterdam, Netherlands)

Published: February 27, 2019

Comparison of Clinical Characteristics and Outcomes in Relapsed Versus De Novo Metastatic Non-Small Cell Lung Cancer.

Comparison of Clinical Characteristics and Outcomes in Relapsed Versus De Novo Metastatic Non-Small Cell Lung Cancer.

Journal: American journal of clinical oncology

Published: September 14, 2018

Impact of number versus location of metastases on survival in stage IV M1b non-small cell lung cancer.

Impact of number versus location of metastases on survival in stage IV M1b non-small cell lung cancer.

Journal: Medical oncology (Northwood, London, England)

Published: June 02, 2018

Loss of tumour-specific ATM protein expression is an independent prognostic factor in early resected NSCLC.

Loss of tumour-specific ATM protein expression is an independent prognostic factor in early resected NSCLC.

Journal: Oncotarget

Published: October 06, 2016

Low ATM protein expression and depletion of p53 correlates with olaparib sensitivity in gastric cancer cell lines.

Low ATM protein expression and depletion of p53 correlates with olaparib sensitivity in gastric cancer cell lines.

Journal: Cell cycle (Georgetown, Tex.)

Published: May 21, 2014

Showing 1-11 of 11

Last Updated: 09/26/2026